April Reynolds
Family · Great Falls, MTNPI 1609219211
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Novo Nordisk at 27.2% of the total. Reporting peaked in 2021 at $1,011 and has fallen 98.1% since, to $20 in 2025. Among family clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $15.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$656
- AbbVie$354
- Esperion Therapeutics, Inc.$191
- Amgen$190
- AstraZeneca$117
- Abbott$101
- plus $805 from 19 others
What the payments were for
- Food & beverage$2,403100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 35 | $656 |
| AbbVie | 36 | $354 |
| Esperion Therapeutics, Inc. | 14 | $191 |
| Amgen(2 entities) | 12 | $190 |
| AstraZeneca | 5 | $117 |
| Abbott | 5 | $101 |
| Bayer | 6 | $100 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $91 |
| Amarin Pharma, Inc. | 4 | $76 |
| Sanofi-aventis U.S. LLC | 4 | $69 |
| Inspire Medical Systems, Inc. | 1 | $68 |
| Lilly USA, LLC | 4 | $61 |
| Astellas Pharma US Inc | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| Novartis | 3 | $40 |
| Pfizer | 2 | $36 |
| Antares Pharma, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Genentech USA, Inc. | 2 | $23 |
| Eisai Inc. | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| GSK | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$122
How this compares
$2,414 in reported general payments places this provider in the 90th percentile of 481 family providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Great Falls
- Amanda MurrayGreat Falls$101K
- Sadra ThomasGreat Falls$7K
- Betsy AkinGreat Falls$6K
- Sydne SkaerGreat Falls$5K
- Sarah PackGreat Falls$4K
- Jennalie GuthmillerGreat Falls$4K
- Casey BarkerGreat Falls$3K
- Courtney FordeGreat Falls$3K
- Kelly TimmerGreat Falls$2K
- Deanna BabbGreat Falls$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.